Polycystic ovary syndrome and adverse pregnancy outcomes: potential role of decidual function
Drug Discoveries & Therapeutics · 2023
DOI: 10.5582/ddt.2023.01096 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Discoveries & Therapeutics, 2023. Verfasst von Lisha Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Reproductive Immunology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Hyperandrogenism, Anovulation, Insulin Resistance. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 84 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory for Reproductive Immunology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
- The Academy of Integrative Medicine of Fudan University, Shanghai, China.
- Shanghai Key Laboratory of Female Reproductive Endocrine-related Diseases, Shanghai, China.
- Reproductive Medicine Center, The Fourth Affiliated Hospital Zhejiang University School of Medicine, Yiwu, Zhejiang, China.
Zitieren
APA
Li, L., Ge, H., Zhou, J., Wang, J., & Wang, L. (2023). Polycystic ovary syndrome and adverse pregnancy outcomes: potential role of decidual function. Drug Discoveries & Therapeutics. https://doi.org/10.5582/ddt.2023.01096
Vancouver
Li L, Ge H, Zhou J, Wang J, Wang L. Polycystic ovary syndrome and adverse pregnancy outcomes: potential role of decidual function. Drug Discoveries & Therapeutics. 2023. doi:10.5582/ddt.2023.01096
BibTeX
@article{Li2023,
author = {Li, Lisha and Ge, Hanting and Zhou, Jing and Wang, Jing and Wang, Ling},
title = {Polycystic ovary syndrome and adverse pregnancy outcomes: potential role of decidual function},
journal = {Drug Discoveries & Therapeutics},
year = {2023},
doi = {10.5582/ddt.2023.01096}
}
EUVIMED